TCW Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.5M Buy
20,897
+1,011
+5% +$77.9K 0.01% 309
2025
Q4
$1.58M Buy
+19,886
New +$1.57M 0.01% 303
2025
Q3
Sell
-18,999
Closed -$1.31M 275
2025
Q2
$1.31M Buy
18,999
+396
+2% +$26K 0.01% 286
2025
Q1
$1.26M Buy
18,603
+1,002
+6% +$60K 0.01% 287
2024
Q4
$790K Buy
17,601
+435
+3% +$24.4K 0.01% 317
2024
Q3
$1.08M Sell
17,166
-405
-2% -$23.6K 0.01% 296
2024
Q2
$1.04M Sell
17,571
-357
-2% -$22.3K 0.01% 302
2024
Q1
$1.43M Sell
17,928
-2,401
-12% -$183K 0.01% 273
2023
Q4
$1.61M Buy
+20,329
New +$1.45M 0.02% 274
2018
Q4
Sell
-10,163
Closed -$800K 331
2018
Q3
$800K Sell
10,163
-235
-2% -$16.8K 0.01% 288
2018
Q2
$670K Sell
10,398
-16,873
-62% -$1.11M 0.01% 287
2018
Q1
$1.7M Buy
27,271
+1,142
+4% +$81.9K 0.01% 235
2017
Q4
$1.9M Sell
26,129
-840,817
-97% -$61.1M 0.02% 227
2017
Q3
$70.5M Sell
866,946
-228,656
-21% -$18.1M 0.56% 65
2017
Q2
$88.2M Sell
1,095,602
-456,467
-29% -$36M 0.73% 54
2017
Q1
$122M Sell
1,552,069
-523,502
-25% -$41.8M 1.02% 36
2016
Q4
$164M Sell
2,075,571
-273,129
-12% -$22.1M 1.23% 22
2016
Q3
$209M Buy
2,348,700
+362,396
+18% +$34.2M 1.59% 13
2016
Q2
$190M Buy
1,986,304
+61,952
+3% +$6.17M 1.44% 17
2016
Q1
$200M Buy
1,924,352
+430,506
+29% +$41.9M 1.46% 15
2015
Q4
$146M Buy
1,493,846
+580,705
+64% +$56.9M 1.05% 34
2015
Q3
$88.1M Buy
913,141
+788,030
+630% +$82.8M 0.63% 64
2015
Q2
$13.1M Sell
125,111
-240,849
-66% -$24.6M 0.08% 145
2015
Q1
$37.8M Sell
365,960
-45,257
-11% -$4.58M 0.18% 123
2014
Q4
$39.6M Sell
411,217
-241,518
-37% -$21.3M 0.17% 123
2014
Q3
$52M Sell
652,735
-16,784
-3% -$1.32M 0.21% 120
2014
Q2
$50.5M Sell
669,519
-22,794
-3% -$1.72M 0.21% 110
2014
Q1
$51.8M Sell
692,313
-1,004
-0.1% -$70.9K 0.22% 99
2013
Q4
$49.6M Sell
693,317
-22,435
-3% -$1.44M 0.21% 103
2013
Q3
$40.6M Buy
715,752
+4,019
+0.6% +$239K 0.19% 107
2013
Q2
$40.7M Buy
+711,733
New +$41.2M 0.2% 103

Other funds holding CVS

TCW Group's CVS Position: Q1 2026 in Review

TCW Group increased its CVS Health (CVS) stake by 5.1% in Q1 2026, buying an estimated $77.9K and bringing the position to 20,897 shares worth $1.5M. The position accounts for 0.01% of the portfolio, ranked #309.

TCW Group first reported a position in CVS in Q2 2013 and has held it in 31 quarters since. The position peaked at $209M in Q3 2016. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • TCW Group held 20,897 shares of CVS Health worth $1.5M as of Q1 2026.
  • TCW Group bought 1,011 CVS Health shares in Q1 2026, an estimated $77.9K.
  • CVS Health made up 0.01% of TCW Group's portfolio in Q1 2026, its #309 holding.
  • TCW Group first reported a position in CVS Health in Q2 2013 and has held it in 31 quarters since.
  • TCW Group's CVS Health position peaked at $209M in Q3 2016.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on TCW Group's 13F filing for Q1 2026, filed 14 May 2026.